300mg po qhs or 150mg po bid.
Maintenance: 150mg po qhs.
Erosive esophagitis: 150mg po q6h.
(IV/IM): 50mg q6-8h. Continuous infusion: 6.25mg/hr (higher doses are possible).
[>50 ml/min]: No changes.
[0 – 49]: 150mg po q24h or 50mg IV q18-24h. If needed, interval may be
increased to q12h if patient is carefully monitored.
150mg po q24h or 50mg IV q18-24h. Schedule doses after dialysis on
National Institutes of Health, U.S. National Library of Medicine,
DailyMed Database. Provides access to the latest drug monographs submitted to the
Food and Drug Administration (FDA). Please review the latest applicable package insert for
additional information and possible updates. A local search
option of this data can be found here.
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical
judgment. Neither GlobalRPh Inc. nor any other party involved in the
preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.PLEASE READ THE DISCLAIMER
BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU
AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read